rivastigmine
PolandMedications containing this active substance
-
Atmina
Form: plaster, transdermal system
Active substance Dosage rivastigmine 4.6 mg/24 h ATC: N06DA03
Manufacturer: Luye Pharma AG
-
Atmina
Form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC: N06DA03
Manufacturer: Luye Pharma AG
-
Evertas
Form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC: N06DA03
Manufacturer: Zentiva, joint-stock company
-
Evertas
Form: plaster, transdermal system
Active substance Dosage rivastigmine 19.2 mg ATC: N06DA03
Manufacturer: Luye Pharma AG Zentiva SA
-
Rivaldo
Form: capsules, hard
Active substance Dosage rivastigmine 1.5 mg ATC: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Rivaldo
Form: capsules, hard
Active substance Dosage rivastigmine 3 mg ATC: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Rivaldo
Form: capsules, hard
Active substance Dosage rivastigmine 4.5 mg ATC: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Rivaldo
Form: capsules, hard
Active substance Dosage rivastigmine 6 mg ATC: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Rivastigmine mylan
Form: plaster, transdermal system
Active substance Dosage rivastigmine 6.9 mg ATC: N06DA03
Manufacturer: Luye Pharma AG
-
Rivastigmine mylan
Form: plaster, transdermal system
Active substance Dosage rivastigmine 13.8 mg ATC: N06DA03
Manufacturer: Luye Pharma AG